Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Depreciation & Amortization (CF) (2022 - 2025)

GE HealthCare Technologies' Depreciation & Amortization (CF) history spans 4 years, with the latest figure at $74.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 13.85% year-over-year to $74.0 million, compared with a TTM value of $287.0 million through Dec 2025, up 7.09%, and an annual FY2025 reading of $287.0 million, up 7.09% over the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $74.0 million at GE HealthCare Technologies, down from $75.0 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $75.0 million in Q3 2025, with the low at $56.0 million in Q1 2022.
  • Average Depreciation & Amortization (CF) over 4 years is $64.4 million, with a median of $64.5 million recorded in 2023.
  • Biggest YoY gain for Depreciation & Amortization (CF) was 13.85% in 2025; the steepest drop was 2.94% in 2025.
  • Tracing GEHC's Depreciation & Amortization (CF) over 4 years: stood at $59.0 million in 2022, then grew by 1.69% to $60.0 million in 2023, then increased by 8.33% to $65.0 million in 2024, then rose by 13.85% to $74.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Depreciation & Amortization (CF) are $74.0 million (Q4 2025), $75.0 million (Q3 2025), and $72.0 million (Q2 2025).